First Header Logo Second Header Logo

Risk Factors for Administration of Additional Reversal Following Neuromuscular Blockade with Rocuronium in Children: A Retrospective Case-Control Study.

Vishneski SR, Saha AK, Fram MR, Templeton LB, Lee LK, Ririe DG, Goenaga-Diaz EJ, Smith LD, Templeton TW. Risk Factors for Administration of Additional Reversal Following Neuromuscular Blockade with Rocuronium in Children: A Retrospective Case-Control Study. Paediatr Anaesth. 2022 Apr 19.

View in: PubMed